Congenital adrenal hyperplasia classification: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
(One intermediate revision by the same user not shown) | |||
Line 6: | Line 6: | ||
! align="center" style="background:#DCDCDC;" rowspan="2" colspan="2" |Disease | ! align="center" style="background:#DCDCDC;" rowspan="2" colspan="2" |Disease | ||
! align="center" style="background:#DCDCDC;" colspan="2" |History and symptoms | ! align="center" style="background:#DCDCDC;" colspan="2" |History and symptoms | ||
! align="center" style="background:#DCDCDC;" colspan=" | ! align="center" style="background:#DCDCDC;" colspan="3" |Laboratory findings | ||
! align="center" style="background:#DCDCDC;" |Defective gene | ! align="center" style="background:#DCDCDC;" |Defective gene | ||
|- | |- | ||
!Blood pressure | !Blood pressure | ||
!Genitalia | !Genitalia | ||
! | !Increased | ||
!Decreased | |||
!K levels | !K levels | ||
! | ! | ||
Line 26: | Line 27: | ||
* Male: normal or scrotal pigmentation and large phallus | * Male: normal or scrotal pigmentation and large phallus | ||
| | | | ||
* [[Deoxycorticosterone]] | |||
* | * 11-Deoxy-[[cortisol]] | ||
* | * [[17-Hydroxyprogesterone|17-hydroxyprogesterone]], mild elevation | ||
| | |||
* [[Cortisol]] | |||
* [[Corticosterone]] | |||
* | * [[Aldosterone]] | ||
* Corticosterone | |||
* | |||
| | | | ||
* High in salt wasting type | * High in salt wasting type | ||
Line 47: | Line 46: | ||
* Female: virilization after puberty | * Female: virilization after puberty | ||
* Male: normal appearance | * Male: normal appearance | ||
| | | | ||
* 17- | * [[17-Hydroxyprogesterone|17-hydroxyprogesterone]] | ||
* Exaggerated | * Exaggerated [[Androstenedione]], [[DHEA]], and [[17-Hydroxyprogesterone|17-hydroxyprogesterone]] | ||
response to ACTH | response to [[ACTH]] | ||
| | |||
| | | | ||
* Normal | * Normal | ||
Line 56: | Line 56: | ||
* CYP21A1 and CYP21A2 gene | * CYP21A1 and CYP21A2 gene | ||
|- | |- | ||
| align="center" style="padding: 5px 5px; background: #DCDCDC;" colspan="2" | | | align="center" style="padding: 5px 5px; background: #DCDCDC;" colspan="2" |[[17 alpha-hydroxylase deficiency|17-α hydroxylase deficiency]] | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Hypertension | * Hypertension | ||
Line 63: | Line 63: | ||
* Male: ambiguous | * Male: ambiguous | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | * [[Deoxycorticosterone]] | ||
* [[Corticosterone]] | |||
* | * [[Progesterone]] | ||
| | |||
* [[Cortisol]] | |||
* [[Aldosterone]] | |||
| | | | ||
* Low | * Low | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | * CYP17A1 | ||
|- | |- | ||
| align="center" style="padding: 5px 5px; background: #DCDCDC;" colspan="2" |11β-hydroxylase deficiency | | align="center" style="padding: 5px 5px; background: #DCDCDC;" colspan="2" |[[11β-hydroxylase deficiency|11-β hydroxylase deficiency]] | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Hypertension | * Hypertension | ||
Line 79: | Line 82: | ||
* Male: normal or scrotal pigmentation and large phallus | * Male: normal or scrotal pigmentation and large phallus | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | * [[Deoxycorticosterone]] | ||
* 11-Deoxy-[[cortisol]] | |||
* | * [[17-Hydroxyprogesterone|17-hydroxyprogesterone]], mild elevation | ||
| | |||
* [[Cortisol]] | |||
* [[Corticosterone]] | |||
* [[Aldosterone]] | |||
| | | | ||
* Low | * Low | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | * CYP11B1 | ||
|- | |- | ||
| align="center" style="padding: 5px 5px; background: #DCDCDC;" colspan="2" | | | align="center" style="padding: 5px 5px; background: #DCDCDC;" colspan="2" |3β-Hydroxysteroid Dehydrogenase | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | |||
| | |||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | | ||
* [[Dehydroepiandrosterone]] | |||
* [[17-hydroxypregnenolone]] | |||
* [[Pregnenolone]] | |||
| | | | ||
* [[Cortisol]] | |||
* [[Aldosterone]] | |||
* Cortisol | |||
* Aldosterone | |||
| | | | ||
* High | * High | ||
Line 105: | Line 112: | ||
| | | | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | | ||
| | |||
| | | | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 112: | Line 120: | ||
| | | | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | | ||
| | |||
| | | | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 119: | Line 128: | ||
| | | | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | | ||
| | |||
| | | | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | | ||
|} | |} |
Latest revision as of 15:25, 1 August 2017
Congenital adrenal hyperplasia main page |
Classification
Congenital adrenal hyperplasia is classified into seven types based on the genetic causes that lead to hyperplasia and hormonal imbalance.
Disease | History and symptoms | Laboratory findings | Defective gene | ||||
---|---|---|---|---|---|---|---|
Blood pressure | Genitalia | Increased | Decreased | K levels | |||
21-hydroxylase deficiency | Classic type |
|
|
|
|
| |
Non-classic type |
|
|
response to ACTH |
|
| ||
17-α hydroxylase deficiency |
|
|
|
| |||
11-β hydroxylase deficiency |
|
|
|
|
| ||
3β-Hydroxysteroid Dehydrogenase |
|
||||||
Cytochrome P450-oxidoreductase (POR) deficiency (ORD) | |||||||
Congenital lipoid adrenal hyperplasia | |||||||
Cholesterol side-chain cleavage enzyme deficiency |